Rare Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027Segmented By Indication (Gastroenterology Disease, Endocrine & Metabolism Disorders Disease, Cardiovascular Disorders, Hematology & Oncology Disease, Others), By Trait Type (Inherited v/s Acquired), By Test Type (Genetic Tests, General Lab Tests, Diagnostic Imaging, Others), By Technology (Next Generation Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays, Others), By Sample Type (DNA Sample, Blood Sample, Saliva Sample, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others), By company and By Region
The global rare disease diagnostics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the growing incidence of rare disorders, adopt... もっと見る
SummaryThe global rare disease diagnostics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the growing incidence of rare disorders, adoption of advanced technology, and increase in investments in R&D are impelling the growth of the market. Rare diseases or orphan diseases is any disease that affects a small percentage of the population. The other factors supporting the market’s growth are, increasing government initiatives for spreading awareness, expanding patient registry for rare diseases, declining sequencing cost, rising geriatric population, the growing launch of programs & new product development in rare disease diagnosis, and rise in research and development activities.The rising incidence of rare disorders will fuel the market growth. Rare diseases are not rarer as there are many people who are suffering from the disease. They affect more people than the combination of AIDS & Cancer. For instance, as per the European Journal of Human Genetics, the number of people living with a rare disease is estimated at 300 million across the globe. Owing to the rise in the number of people suffering from rare diseases such as Agammaglobulinemia, Goodpasture Syndrome, Granulomatosis with Polyangiitis (GPA, formerly Wegener Granulomatosis), Leukocyte Adhesion Deficiency, Pediatric Bruton Agammaglobulinemia, Pediatric Severe Combined Immunodeficiency, Schnitzler Syndrome and others, the surge in demand for the diagnosis is bolstering the growth of the market. Technological Advancements in Disease Diagnosis The rise in the adoption of advanced technology in the field of rare diseases diagnostic is augmenting the growth of the market. New innovative technologies and advancements such as artificial intelligence (AI), NGS-based testing, and automation technology are assisting in reducing time and cost and enabling more accurate diagnosis when compared to standard manual analysis. For instance, increase in the adoption of the Whole Exome Sequencing (WES) genetic testing tool. The technique aims only at exons, which make 1-2% of the whole genome and include 80% of all disease-causing mutations. Rising Awareness of diagnosis of rare diseases Early diagnosis of rare diseases is essential as it can help people to treat these conditions timely without suffering. Thus, the rise in awareness about rare diseases among the general public and patients is facilitating the growth of the market. Various initiatives by government and non-government organizations are taken to make people aware of the early diagnosis and treatment of the disease. For instance, every year, rare diseases day at NIH takes place, which aims to raise awareness about rare diseases and the impact they have on patient’s lives. Market Segmentation The global rare disease diagnostics market is segmented into indication, trait type, test type, technology, sample type, end user, and company. Based on indication, the market is divided into gastroenterology disease, endocrine & metabolism disorders disease, cardiovascular disorders, hematology & oncology disease, and others. Based on trait type, the market is divided into inherited and acquired. Based on test type, the market is segmented into genetic tests, general lab tests, diagnostic imaging, and others. Based on technology, the market is divided into next-generation sequencing, whole genome sequencing, whole exome sequencing, microarrays, and others. Based on sample type, the market is divided into DNA samples, blood sample, saliva samples, and others. Based on end-user, the market is divided into hospitals & clinics, academic & research institutes, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising occurrences of rare diseases in the country. Market Players Agilent Technologies, Inc., Illumina, Inc., QIAGEN NV, PerkinElmer, Inc, Quest Diagnostics, Inc., CENTOGENE N.V., 23andMe, Inc., 3billion, Inc., Eurofins Scientific SE, and Invitae Corporation are some of the leading companies operating in the market. Report Scope: In this report, global rare disease diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: • Rare Disease Diagnostics Market, By Indication: o Gastroenterology Disease o Endocrine & Metabolism Disorders Disease o Cardiovascular Disorders o Hematology & Oncology Disease o Others • Rare Disease Diagnostics Market, By Trait Type: o Inherited o Acquired • Rare Disease Diagnostics Market, By Test Type: o Genetic Tests o General Lab Tests o Diagnostic Imaging o Others • Rare Disease Diagnostics Market, By Technology: o Next Generation Sequencing o Whole Genome Sequencing o Whole Exome Sequencing o Microarrays o Others • Rare Disease Diagnostics Market, By Sample Type: o DNA Sample o Blood Sample o Saliva Sample o Others • Rare Disease Diagnostics Market, By End User: o Hospitals & Clinics o Academic & Research Institutes o Others • Rare Disease Diagnostics Market, By Region: o North America United States Canada Mexico o Asia-Pacific China India Japan Australia South Korea o Europe & CIS Germany France United Kingdom Spain Italy o South America Brazil Argentina Colombia o Middle East & Africa South Africa Saudi Arabia UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in Global Rare Disease Diagnostics Market Available Customizations: With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report: Company Information • Detailed analysis and profiling of additional market players (up to five). Table of Contents1. Product Overview2. Research Methodology 3. Executive Summary 4. Impact of COVID-19 on Global Rare Disease Diagnostics Market 5. Voice of Customer 6. Global Rare Disease Diagnostics Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Indication (Gastroenterology Disease, Endocrine & Metabolism Disorders Disease, Cardiovascular Disorders, Hematology & Oncology Disease, Others) 6.2.2. By Trait Type (Inherited v/s Acquired) 6.2.3. By Test Type (Genetic Tests, General Lab Tests, Diagnostic Imaging, Others) 6.2.4. By Technology (Next Generation Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays, Others) 6.2.5. By Sample Type (DNA Sample, Blood Sample, Saliva Sample, Others) 6.2.6. By End User (Hospitals & Clinics, Academic & Research Institutes, Others) 6.2.7. By Region 6.2.8. By Company (2021) 6.3. Market Map 7. North America Rare Disease Diagnostics Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Indication 7.2.2. By Trait Type 7.2.3. By Test Type 7.2.4. By Technology 7.2.5. By Sample Type 7.2.6. By End User 7.2.7. By Country 7.3. North America: Country Analysis 7.3.1. United States Rare Disease Diagnostics Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Indication 7.3.1.2.2. By Trait Type 7.3.1.2.3. By Test Type 7.3.1.2.4. By Technology 7.3.1.2.5. By Sample Type 7.3.1.2.6. By End User 7.3.2. Canada Rare Disease Diagnostics Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Indication 7.3.2.2.2. By Trait Type 7.3.2.2.3. By Test Type 7.3.2.2.4. By Technology 7.3.2.2.5. By Sample Type 7.3.2.2.6. By End User 7.3.3. Mexico Rare Disease Diagnostics Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Indication 7.3.3.2.2. By Trait Type 7.3.3.2.3. By Test Type 7.3.3.2.4. By Technology 7.3.3.2.5. By Sample Type 7.3.3.2.6. By End User 8. Europe Rare Disease Diagnostics Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Indication 8.2.2. By Trait Type 8.2.3. By Test Type 8.2.4. By Technology 8.2.5. By Sample Type 8.2.6. By End User 8.2.7. By Country 8.3. Europe: Country Analysis 8.3.1. France Rare Disease Diagnostics Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Indication 8.3.1.2.2. By Trait Type 8.3.1.2.3. By Test Type 8.3.1.2.4. By Technology 8.3.1.2.5. By Sample Type 8.3.1.2.6. By End User 8.3.2. Germany Rare Disease Diagnostics Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Indication 8.3.2.2.2. By Trait Type 8.3.2.2.3. By Test Type 8.3.2.2.4. By Technology 8.3.2.2.5. By Sample Type 8.3.2.2.6. By End User 8.3.3. United Kingdom Rare Disease Diagnostics Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Indication 8.3.3.2.2. By Trait Type 8.3.3.2.3. By Test Type 8.3.3.2.4. By Technology 8.3.3.2.5. By Sample Type 8.3.3.2.6. By End User 8.3.4. Italy Rare Disease Diagnostics Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Indication 8.3.4.2.2. By Trait Type 8.3.4.2.3. By Test Type 8.3.4.2.4. By Technology 8.3.4.2.5. By Sample Type 8.3.4.2.6. By End User 8.3.5. Spain Rare Disease Diagnostics Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Indication 8.3.5.2.2. By Trait Type 8.3.5.2.3. By Test Type 8.3.5.2.4. By Technology 8.3.5.2.5. By Sample Type 8.3.5.2.6. By End User 9. Asia-Pacific Rare Disease Diagnostics Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Indication 9.2.2. By Trait Type 9.2.3. By Test Type 9.2.4. By Technology 9.2.5. By Sample Type 9.2.6. By End User 9.2.7. By Country 9.3. Asia-Pacific: Country Analysis 9.3.1. China Rare Disease Diagnostics Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Indication 9.3.1.2.2. By Trait Type 9.3.1.2.3. By Test Type 9.3.1.2.4. By Technology 9.3.1.2.5. By Sample Type 9.3.1.2.6. By End User 9.3.2. India Rare Disease Diagnostics Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Indication 9.3.2.2.2. By Trait Type 9.3.2.2.3. By Test Type 9.3.2.2.4. By Technology 9.3.2.2.5. By Sample Type 9.3.2.2.6. By End User 9.3.3. Japan Rare Disease Diagnostics Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Indication 9.3.3.2.2. By Trait Type 9.3.3.2.3. By Test Type 9.3.3.2.4. By Technology 9.3.3.2.5. By Sample Type 9.3.3.2.6. By End User 9.3.4. South Korea Rare Disease Diagnostics Market Outlook 9.3.4.1. Market Size & Forecast 9.3.4.1.1. By Value 9.3.4.2. Market Share & Forecast 9.3.4.2.1. By Indication 9.3.4.2.2. By Trait Type 9.3.4.2.3. By Test Type 9.3.4.2.4. By Technology 9.3.4.2.5. By Sample Type 9.3.4.2.6. By End User 9.3.5. Australia Rare Disease Diagnostics Market Outlook 9.3.5.1. Market Size & Forecast 9.3.5.1.1. By Value 9.3.5.2. Market Share & Forecast 9.3.5.2.1. By Indication 9.3.5.2.2. By Trait Type 9.3.5.2.3. By Test Type 9.3.5.2.4. By Technology 9.3.5.2.5. By Sample Type 9.3.5.2.6. By End User 10. South America Rare Disease Diagnostics Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Indication 10.2.2. By Trait Type 10.2.3. By Test Type 10.2.4. By Technology 10.2.5. By Sample Type 10.2.6. By End User 10.2.7. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Rare Disease Diagnostics Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Indication 10.3.1.2.2. By Trait Type 10.3.1.2.3. By Test Type 10.3.1.2.4. By Technology 10.3.1.2.5. By Sample Type 10.3.1.2.6. By End User 10.3.2. Argentina Rare Disease Diagnostics Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Indication 10.3.2.2.2. By Trait Type 10.3.2.2.3. By Test Type 10.3.2.2.4. By Technology 10.3.2.2.5. By Sample Type 10.3.2.2.6. By End User 10.3.3. Colombia Rare Disease Diagnostics Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Indication 10.3.3.2.2. By Trait Type 10.3.3.2.3. By Test Type 10.3.3.2.4. By Technology 10.3.3.2.5. By Sample Type 10.3.3.2.6. By End User 11. Middle East and Africa Rare Disease Diagnostics Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Indication 11.2.2. By Trait Type 11.2.3. By Test Type 11.2.4. By Technology 11.2.5. By Sample Type 11.2.6. By End User 11.2.7. By Country 11.3. MEA: Country Analysis 11.3.1. South Africa Rare Disease Diagnostics Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast 11.3.1.2.1. By Indication 11.3.1.2.2. By Trait Type 11.3.1.2.3. By Test Type 11.3.1.2.4. By Technology 11.3.1.2.5. By Sample Type 11.3.1.2.6. By End User 11.3.2. Saudi Arabia Rare Disease Diagnostics Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Indication 11.3.2.2.2. By Trait Type 11.3.2.2.3. By Test Type 11.3.2.2.4. By Technology 11.3.2.2.5. By Sample Type 11.3.2.2.6. By End User 11.3.3. UAE Rare Disease Diagnostics Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Indication 11.3.3.2.2. By Trait Type 11.3.3.2.3. By Test Type 11.3.3.2.4. By Technology 11.3.3.2.5. By Sample Type 11.3.3.2.6. By End User 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends & Developments 14. Competitive Landscape (Inclusive of SWOT Analysis) 14.1. Agilent Technologies, Inc. 14.2. Illumina, Inc. 14.3. QIAGEN NV 14.4. PerkinElmer, Inc 14.5. Quest Diagnostics, Inc. 14.6. CENTOGENE N.V. 14.7. 23andMe, Inc. 14.8. 3billion, Inc. 14.9. Eurofins Scientific SE 14.10. Invitae Corporation 15. Strategic Recommendations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
TechSci Research社のヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(diagnostic)の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|